Skip to content

Large study shows the hepatic safety of HIV therapy

Treatment with raltegravir increases the risk of mild muscular side-effects

Any reduction in viral load has immunologic benefits for people with HIV who have triple-class treatment failure

Neurocognitive impairment results in poorer adherence to HIV therapy

Smoking has a bigger impact on the prognosis of HIV-positive patients than HIV-related factors

Poor CD4 response to HIV treatment increases risk of death from non-AIDS-related illnesses, even for those with higher baseline counts

Combined oral contraception has less effect on nevirapine than efavirenz levels

Vitamin D deficiency increases risk of TB among people starting HIV therapy

Treatment with a protease inhibitor during the first trimester of pregnancy increases the risk of pre-term birth